Passive immunization against varicella-zoster infections and other modes of therapy.
D000328:Adult; D001803:Blood Transfusion; D002644:Chickenpox / Q000150:complications / Q000276:immunology / Q000517:prevention & control*; D002648:Child; D003428:Cross Infection / Q000517:prevention & control; D003561:Cytarabine / Q000627:therapeutic use; D005260:Female; D006562:Herpes Zoster / Q000150:complications / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D007065:Idoxuridine / Q000627:therapeutic use; D007154:Immune System Diseases / Q000150:complications; D007112:Immunity, Maternally-Acquired; D007114:Immunization; D007136:Immunoglobulins / Q000627:therapeutic use*; D007369:Interferon Inducers / Q000627:therapeutic use; D007938:Leukemia / Q000150:complications; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control; D013256:Steroids / Q000627:therapeutic use
D007136:Immunoglobulins; D007369:Interferon Inducers; D013256:Steroids; D003561:Cytarabine; D007065:Idoxuridine